Clinical Trials in Maryland

Showing 23121-23140 of 23,284 trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

HallucinationsPsychosesParkinson's Disease

ACADIA Pharmaceuticals Inc.60 participantsStarted Mar 2004

Fountain Valley, California, United States • Sunnyvale, California, United States • Danbury, Connecticut, United States +10 more locations

COMPLETEDPhase 217 miles

Xcellerated T CellsTM in Patients With Multiple Myeloma

NCT00078065

This trial is a phase II, randomized study of patients with multiple myeloma. All patients will receive Xcellerated T Cells, with or without prior fludarabine therapy. 15 patients in each study arm will be followed for 6 months.

Multiple Myeloma

Xcyte Therapies30 participantsStarted Nov 2003

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +6 more locations

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Xcellerated T CellsTM in Patients With Multiple Myeloma

Find Trials by Condition in Maryland

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Efficacy of Parent-Child Dieting Plans Incorporating Medifast Meal Replacements for Weight Loss

Effects of Herbal Products on Metabolism and Hunger

Trial of New Dietary Treatment of Diabetes

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Study of NS-9 in Patients With Liver Metastases

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain